Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Different Domperidone Dosages on Reflux Esophagitis Treated with Esomeprazole
TCTR20260417013Phase 0Completed
- Sponsor
- Beijing Integrated Traditional and Western Medicine Hospital
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 0, randomised trial of domperidone in erosive esophagitis (EE) and gastroesophageal reflux disease (GERD), sponsored by Beijing Integrated Traditional and Western Medicine Hospital. Started Jan 2022; status: completed.
02
Drugs
domperidone
03
Conditions
erosive esophagitis (EE)gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on TCTR20260417013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260417013.